[22] [23] Current guidelines from the American Society for Metabolic and Bariatric Surgery and International Federation for the Surgery of Obesity and Metabolic Disorders (2022) recommend considering surgery for patients with BMI 35 kg/m regardless of comorbidities and for those with BMI 30-34.9 kg/m with metabolic disease
Mounjaro contains the medication Tirzepatide, a dual-action medication that targets both GLP-1 and GIP receptors
This can happen for several reasons, such as how the body responds to the medication, existing health issues, or other drugs used with Tirzepatide
Potential Side Effects and How to Manage Them: While Tirzepatide is generally well-tolerated, some individuals may experience side effects, especially during the first week as the body adjusts
Tirzepatide vs Semaglutide Weight Loss and Side Effects Tirzepatide often produces greater average weight loss
Ongoing Support : We provide continuous monitoring to ensure you are achieving your desired results and making adjustments as needed